Caco-2 cell culture as a model for Famotidine absorption

Drug Delivery: Journal of Delivery and Targeting of Therapeutic Agents

Volumn 12, Issue 1, 2005, Pages 27-33

  Deǧim, Zelihagül ^a   Unal, Nilay ^b   Essiz, Dinç ^c   Abbasoǧlu, Ufuk ^a  

^a GAZI UNIVERSITY   (Turkey)

^b Foot and Mouth Disease Institute   (Turkey)

^c ANKARA UNIVERSITY   (Turkey)

Author keywords

Caco 2; Famotidine; HPLC; Microspheres; Poly(Lactide Co Glycolide)

Indexed keywords

FAMOTIDINE; MICROSPHERE; POLYGLACTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CULTURE; CELL MEMBRANE PERMEABILITY; CELL STRAIN CACO 2; COLON ADENOCARCINOMA; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DOSAGE FORM; DRUG EFFECT; DRUG FORMULATION; DRUG PENETRATION; DRUG TRANSPORT; EMULSION; FEMALE; MOUSE; NONHUMAN; POLYMERIZATION; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; TIGHT JUNCTION;

ABSORPTION; ANIMALS; CACO-2 CELLS; FAMOTIDINE; FEMALE; HUMANS; MICE; MICROSPHERES;

EID: 11244311812     PISSN: 10717544     EISSN: None     Source Type: Journal    
DOI: 10.1080/10717540590889664     Document Type: Article

References (19)

1. Artursson, P. 1991. Cell cultures as models for drug absorption across the intestinal mucosa. Therap. Drug Carrier Sys. 8:305-330.
2. Birnbaum, D. T., Kosmala, J. D., Henthom, D. B., and Peppas, L. B. 2000. Controlled release of β estradiol from PLAGA microparticles: the effect of organic phase solvent on encapsulation and release. J. Cont. Rel. 65:375-387.
3. Camenisch, G., Folkers, G., and Waterbeemd, H. 1997. Comparison of passive drug transport through Caco-2 cells and artificial membranes. Int. J. Pharm. 147:61-70.
4. Caro, I., Boulenc, X., Rousset, M., Meunier, V., Bourrié, M., Julian, B., Joyeux, H., Roques, C., Berger, Y., Zweibaum, A., and Fabre, G. 1995. Characterisation of a newly isolated caco 2 clone(TC-V), as a model of transport processes and biotransformation of drugs. Int. J. Pharmaceuts. 116:147-158.
5. Castewllanos, I. J., Carrasquillo, K. G., Lopez, J. J., Alvarez, M., and Griebenow, K. 2000. Encapsulation of bovine serum albumin in poly(lactide-coglycolide) microspheres by the solid in on in water technique. J. Pharm. Pharmacol. 53:167-178.
6. Deǧim, Z., Ünal, N., and Abbasoǧlu, U. 2001. Caco-2 cell culture as a model for famotidine and insuline absorption across the intestinal mucosa. World Congress of Pharmacy and Pharmaceutical Sciences, 61st International Congress of FIP, Singapore, Abstracts, 53.
7. Deǧim, Z., and Aǧabeyoǧlu, İ. 2002. Nonisothermal stability tests of famotidine and nizatidine. Il Farmaco 57:729-735.
8. Desai, M. P., Labhasetwar, V., Walter, E., Levy, R. J., and Amidon, G. L. 1997. The mechanism of uptake of biodegradable microparticles in Caco-2 cells is size dependent. Pharm. Res. 14:1568-1573.
9. Desai, M. P., Labhasetwar, V., Amidon, G. L., and Levy, R. J. 1996. Gastrointestinal uptake of biodegradable microparticles: Effect of particle size. Pharm. Res. 13(12):1838-1845.
10. Foster, K. A., Yaedenian, M., and Audus, K. L. 2001. Microparticulate uptake mechanisms of in vitro cell culture models of the respiratory epithelium. J. Pharm. Pharmacol. 53:57-66.
11. 2-antagonists. Pharm. Res. 15:53-57.
12. Greenwood, R., and Al-Achi, A. 1997. Human insulin diffusion profile through a layer of caco 2 cells. Drug Dev. Ind. Pharm. 23:221-224.
13. Hovgaard, L., Brondsted, H., and Nielsen, H. M. 1995. Drug delivery studies in caco-2 monolayers. II. absorption enhancer effects of lysophosphatdylcholines. Int. J. Pharm. 114:141-149.
14. Kim, T. K., and Burgess, D. J. 2001. Formulation and release characteristics of poly(lactic-cc glycolic acid) microspheres containing chemically modified protein. J. Pharm. Pharmacol. 53:23-31.
15. Lentz, K. A., Hayashi, J., Lucisano, L. J., and Polli, J. E. 2000. Development of a more rapid, reduced serum culture system for caco-2 monolayers and application to the biopharmaceutics classication system. Int. J. Pharmaceut. 200:41-51.
16. O'leary, G., Deǧim, Z., Gumbleton, M., and Mcguigan, C. 1996. Permeability of caco-2 novel d4t-monophosphate prodrugs. Eur. J. Pharmaceuti. Sci. (4):S194.
17. Tanaka, Y., Taki Y., Sakane, T., Tanekazu, N., Sezaki, H., and Yamashita, S. 1995. Characterization of drug transport through tight-juntional pathway in caco-2 monolayer: comparison with isolated rat jejenum and colon. Pharmaceut. Res. 12:523-528.
18. Tunçay, M., Çaliş, S., Kaş, H. S., Ercan, M. T., Peksoy, İ., and Hincal, A. 2000. Diclofena sodium incorporated PLGA (50:50) microspheres: formulation considerations and in vitro/in vivo evaluation. Int. J. Pharm. 195:179-188.
19. Vanrell, R. H., and Refojo, M. F. 2001. Biodegradable microspheres for vitreo-retinal drudelivery. Adv Drug Del. Rev. 52:5-16.